Search Results - "ALANEN, Kalle"

Refine Results
  1. 1

    High-throughput transcriptomic and RNAi analysis identifies AIM1, ERGIC1, TMED3 and TPX2 as potential drug targets in prostate cancer by Vainio, Paula, Mpindi, John-Patrick, Kohonen, Pekka, Fey, Vidal, Mirtti, Tuomas, Alanen, Kalle A, Perälä, Merja, Kallioniemi, Olli, Iljin, Kristiina

    Published in PloS one (28-06-2012)
    “…Prostate cancer is a heterogeneous group of diseases and there is a need for more efficient and targeted methods of treatment. In this study, the potential of…”
    Get full text
    Journal Article
  2. 2

    FZD4 as a Mediator of ERG Oncogene―Induced WNT Signaling and Epithelial-to-Mesenchymal Transition in Human Prostate Cancer Cells by GUPTA, Santosh, ILJIN, Kristiina, SARA, Henri, MPINDI, John Patrick, MIRTTI, Tuomas, VAINIO, Paula, RANTALA, Juha, ALANEN, Kalle, NEES, Matthias, KALLIONIEMI, Olli

    Published in Cancer research (Chicago, Ill.) (01-09-2010)
    “…TMPRSS2-ERG and other gene fusions involving ETS factors and genes with strong promoter elements are common in prostate cancer. Although ERG activation has…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma by Kokko, Linda-Lotta, Hurme, Saija, Maula, Sanna-Mari, Alanen, Kalle, Grénman, Reidar, Kinnunen, Ilpo, Ventelä, Sami

    Published in Oral oncology (01-06-2011)
    “…Summary In several recent studies, CD44 expression has been associated with aggressive behavior in cancers of different types. CD44 expression is also linked…”
    Get full text
    Journal Article
  6. 6

    Stat3 Promotes Metastatic Progression of Prostate Cancer by Abdulghani, Junaid, Gu, Lei, Dagvadorj, Ayush, Lutz, Jacqueline, Leiby, Benjamin, Bonuccelli, Gloria, Lisanti, Michael P, Zellweger, Tobias, Alanen, Kalle, Mirtti, Tuomas, Visakorpi, Tapio, Bubendorf, Lukas, Nevalainen, Marja T

    Published in The American journal of pathology (01-06-2008)
    “…There are currently no effective therapies for metastatic prostate cancer because the molecular mechanisms that underlie the metastatic spread of primary…”
    Get full text
    Journal Article
  7. 7

    Accuracy of 18F-FDG PET/CT, Multidetector CT, and MR Imaging in the Diagnosis of Pancreatic Cysts: A Prospective Single-Center Study by Kauhanen, Saila, Rinta-Kiikka, Irina, Kemppainen, Jukka, Grönroos, Juha, Kajander, Sami, Seppänen, Marko, Alanen, Kalle, Gullichsen, Risto, Nuutila, Pirjo, Ovaska, Jari

    Published in The Journal of nuclear medicine (1978) (01-08-2015)
    “…Accurate diagnosis of the nature of pancreatic cysts is challenging but more important than ever, in part because of the increasing number of incidental cystic…”
    Get full text
    Journal Article
  8. 8

    Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo by Gu, Lei, Vogiatzi, Paraskevi, Puhr, Martin, Dagvadorj, Ayush, Lutz, Jacqueline, Ryder, Amy, Addya, Sankar, Fortina, Paolo, Cooper, Carlton, Leiby, Benjamin, Dasgupta, Abhijit, Hyslop, Terry, Bubendorf, Lukas, Alanen, Kalle, Mirtti, Tuomas, Nevalainen, Marja T

    Published in Endocrine-related cancer (01-06-2010)
    “…There are no effective therapies for disseminated prostate cancer. Constitutive activation of Stat5 in prostate cancer is associated with cancer lesions of…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Inhibition of Transcription Factor Stat5 Induces Cell Death of Human Prostate Cancer Cells by Ahonen, Tommi J., Xie, Jianwu, LeBaron, Matthew J., Zhu, Jianqiong, Nurmi, Martti, Alanen, Kalle, Rui, Hallgeir, Nevalainen, Marja T.

    Published in The Journal of biological chemistry (18-07-2003)
    “…Identifying regulators of prostate cancer cell survival may lead to new therapeutic strategies for prostate cancer. We now report prevalent activation of…”
    Get full text
    Journal Article
  11. 11

    Mannose receptor is a novel ligand for L-selectin and mediates lymphocyte binding to lymphatic endothelium by Irjala, H, Johansson, E L, Grenman, R, Alanen, K, Salmi, M, Jalkanen, S

    Published in The Journal of experimental medicine (15-10-2001)
    “…Continuous lymphocyte recirculation between blood and lymphoid tissues forms a basis for the function of the immune system. Lymphocyte entrance from the blood…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Improved detection of localized prostate cancer using co-registered MRI and 11C-acetate PET/CT by Jambor, Ivan, Borra, Ronald, Kemppainen, Jukka, Lepomäki, Virva, Parkkola, Riitta, Dean, Kirsti, Alanen, Kalle, Arponen, Eveliina, Nurmi, Martti, Aronen, Hannu J., Minn, Heikki

    Published in European journal of radiology (01-11-2012)
    “…We aimed to study the ability of contrast enhanced MRI at 1.5T and 11C-acetate PET/CT, both individually and using fused data, to detect localized prostate…”
    Get full text
    Journal Article
  14. 14

    Functional imaging of localized prostate cancer aggressiveness using 11C-acetate PET/CT and 1H-MR spectroscopy by Jambor, Ivan, Borra, Ronald, Kemppainen, Jukka, Lepomäki, Virva, Parkkola, Riitta, Dean, Kirsti, Alanen, Kalle, Arponen, Eveliina, Nurmi, Martti, Aronen, Hannu J, Minn, Heikki

    Published in The Journal of nuclear medicine (1978) (01-11-2010)
    “…We assessed the ability of (11)C-acetate PET/CT, MRI, and proton MR spectroscopy ((1)H-MRS) to image localized prostate cancer and detect its aggressiveness,…”
    Get full text
    Journal Article
  15. 15

    Vascular Adhesion Protein 1 Mediates Binding of Immunotherapeutic Effector Cells to Tumor Endothelium by Irjala, Heikki, Salmi, Marko, Alanen, Kalle, Grenman, Reidar, Jalkanen, Sirpa

    Published in The Journal of immunology (1950) (01-06-2001)
    “…Tumor-infiltrating lymphocytes (TIL) can be used as an immunotherapeutic tool to treat cancer. Success of this therapy depends on the homing and killing…”
    Get full text
    Journal Article
  16. 16

    Activating mutation (V617F) in the tyrosine kinase JAK2 is absent in locally-confined or castration-resistant prostate cancer by Gu, Lei, Zhu, Xian-Hua, Visakorpi, Tapio, Alanen, Kalle, Mirtti, Tuomas, Edmonston, Tina Bocker, Nevalainen, Marja T

    Published in Analytical cellular pathology (Amsterdam) (01-01-2010)
    “…BACKGROUNDTranscription factor Stat5a/b is highly critical for the viability of human prostate cancer cells in vitro and for prostate tumor growth in vivo…”
    Get full text
    Journal Article
  17. 17

    Altered expression of syndecan-1 in prostate cancer by KIVINIEMI, JOHANNA, KALLAJOKI, MARKKU, KUJALA, IINA, MATIKAINEN, MARJA-TERTTU, ALANEN, KALLE, JALKANEN, MARKKU, SALMIVIRTA, MARKKU

    “…Syndecan‐1 is a cell surface heparan sulfate proteoglycan expressed by epithelial cells. It interacts with growth factors, matrix components, and other…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Prebiopsy multiparametric 3T prostate MRI in patients with elevated PSA, normal digital rectal examination, and no previous biopsy by Jambor, Ivan, Kähkönen, Esa, Taimen, Pekka, Merisaari, Harri, Saunavaara, Jani, Alanen, Kalle, Obsitnik, Branislav, Minn, Heikki, Lehotska, Viera, Aronen, Hannu J.

    Published in Journal of magnetic resonance imaging (01-05-2015)
    “…Purpose To find the diagnostic accuracy of 3T multiparametric magnetic resonance imaging (mpMRI) and mpMRI targeted transrectal ultrasound (TRUS)‐guided biopsy…”
    Get full text
    Journal Article
  20. 20

    Immunohistochemical labelling for prostate-specific antigen in breast carcinomas by ALANEN, K. A, KUOPIO, T, COLLAN, Y. U, KRONQVIST, P, JUNTTI, L, NEVALAINEN, T. J

    Published in Breast cancer research and treatment (01-07-1999)
    “…Immunohistochemical detection of prostate-specific antigen (PSA) is an aid in determining the prostatic origin of metastatic cells. However, small amounts of…”
    Get full text
    Journal Article